• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织因子/蛋白酶激活受体-2 信号通路的抑制可限制恶性脑胶质瘤细胞的增殖、迁移和侵袭。

Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells.

机构信息

Experimental Neurosurgery, Goethe University Hospital, Frankfurt, Germany.

出版信息

Neuroscience. 2010 Feb 17;165(4):1312-22. doi: 10.1016/j.neuroscience.2009.11.049. Epub 2009 Dec 1.

DOI:10.1016/j.neuroscience.2009.11.049
PMID:19958818
Abstract

Tissue factor (TF) is upregulated in several malignant diseases, including gliomas. Here, we demonstrate pronounced differences in the expression of TF and its interactors factor VII and protease-activated receptor 2 (PAR-2) in nine human glioma cell lines (U87, U251, U343, U373, MZ-18, MZ-54, MZ-256, MZ-304, Hs 683) as detected by RT-PCR and Western blot analysis. Inhibition of TF signaling by a neutralizing monoclonal antibody (mAb TF9-10H10) led to significantly reduced proliferation in high-grade astroglial (MZ-18 and MZ-304) and oligodendroglial (Hs 683) cell lines abundantly expressing TF, but not in U373 cells expressing low amounts of TF. Scratch migration assays and Boyden chamber assays indicated that mAb TF9-10H10 and lentiviral knockdown of TF significantly reduced cell migration and invasion of MZ-18, MZ-304 and Hs 683 cells, both under normoxic and hypoxic conditions. Of note, all three cell lines displayed increased cell migration and invasion under hypoxic conditions (1% O(2)), which was associated with enhanced expression of TF and increased phosphorylation of p44/42 mitogen-activated protein kinase (ERK1/2). Silencing of TF blocked activation of the ERK pathway, induction of TF expression and the potentiating effect of hypoxia on cell migration and invasion. RNA interference against PAR-2 abrogated the autocrine effects of TF on cell proliferation, migration and invasion, indicating that TF signals via PAR-2 in glioma cells. Our results suggest an important role for the TF/FVIIa/PAR-2/ERK axis in tumor growth and invasion of glioma and suggest that TF may be a suitable target for the development of novel therapies against high-grade glioma.

摘要

组织因子(TF)在包括神经胶质瘤在内的几种恶性疾病中上调。在这里,我们通过 RT-PCR 和 Western blot 分析证明了 9 个人神经胶质瘤细胞系(U87、U251、U343、U373、MZ-18、MZ-54、MZ-256、MZ-304、Hs 683)中 TF 及其相互作用因子 VII 和蛋白酶激活受体 2(PAR-2)的表达存在明显差异。用中和单克隆抗体(mAb TF9-10H10)抑制 TF 信号导致 TF 表达丰富的高级别星形细胞瘤(MZ-18 和 MZ-304)和少突胶质细胞瘤(Hs 683)细胞系的增殖显著减少,但在 TF 表达量低的 U373 细胞中则没有。划痕迁移实验和 Boyden 室实验表明,mAb TF9-10H10 和慢病毒敲低 TF 显著降低了 MZ-18、MZ-304 和 Hs 683 细胞在常氧和低氧条件下的迁移和侵袭,在低氧条件下(1% O2),所有三种细胞系的迁移和侵袭都增加,这与 TF 的表达增加和丝裂原活化蛋白激酶(ERK1/2)p44/42 的磷酸化增加有关。TF 的沉默阻断了 ERK 途径的激活、TF 表达的诱导以及低氧对细胞迁移和侵袭的增强作用。PAR-2 的 RNA 干扰消除了 TF 对细胞增殖、迁移和侵袭的自分泌作用,表明 TF 通过 PAR-2 在神经胶质瘤细胞中发出信号。我们的研究结果表明,TF/FVIIa/PAR-2/ERK 轴在神经胶质瘤的肿瘤生长和侵袭中具有重要作用,并表明 TF 可能是开发针对高级别神经胶质瘤的新型治疗方法的合适靶点。

相似文献

1
Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells.组织因子/蛋白酶激活受体-2 信号通路的抑制可限制恶性脑胶质瘤细胞的增殖、迁移和侵袭。
Neuroscience. 2010 Feb 17;165(4):1312-22. doi: 10.1016/j.neuroscience.2009.11.049. Epub 2009 Dec 1.
2
Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.凝血因子VII的异位合成激活癌细胞迁移和侵袭。
Cancer Res. 2006 Oct 1;66(19):9453-60. doi: 10.1158/0008-5472.CAN-06-1803.
3
Anti-tissue factor (TF9-10H10) treatment reduces tumor cell invasiveness in a novel migratory glioma model.抗组织因子(TF9-10H10)治疗可降低新型迁移性脑胶质瘤模型中的肿瘤细胞侵袭性。
Neuropathology. 2013 Oct;33(5):515-25. doi: 10.1111/neup.12018. Epub 2013 Feb 5.
4
The expression and the functional roles of tissue factor and protease-activated receptor-2 on SW620 cells.组织因子和蛋白酶激活受体-2在SW620细胞上的表达及功能作用
Oncol Rep. 2008 Nov;20(5):1069-76.
5
Influence of exogenous tissue factor on estrogen receptor alpha expression in breast cancer cells: involvement of beta1-integrin, PAR2, and mitogen-activated protein kinase activation.外源性组织因子对乳腺癌细胞中雌激素受体α表达的影响:β1整合素、蛋白酶激活受体2及丝裂原活化蛋白激酶激活的参与
Mol Cancer Res. 2008 Dec;6(12):1807-18. doi: 10.1158/1541-7786.MCR-08-0109.
6
Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis.蛋白酶体抑制剂上调DR5可有效使胶质瘤细胞对TRAIL诱导的凋亡敏感。
FEBS J. 2008 Apr;275(8):1925-36. doi: 10.1111/j.1742-4658.2008.06351.x. Epub 2008 Mar 13.
7
Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.蛋白酶激活受体-2对于因子VIIa和Xa诱导的乳腺癌细胞信号传导、迁移及侵袭至关重要。
Cancer Res. 2006 Jan 1;66(1):307-14. doi: 10.1158/0008-5472.CAN-05-1735.
8
LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.LRRC4通过减少SDF-1α/CXCR4介导的ERK1/2和Akt信号通路来抑制人胶质母细胞瘤细胞的增殖、侵袭和proMMP-2激活。
J Cell Biochem. 2008 Jan 1;103(1):245-55. doi: 10.1002/jcb.21400.
9
Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.活化的凝血因子 VII 与组织因子的结合通过细胞外信号调节激酶的激活触发平滑肌细胞增殖。
Circulation. 2004 Jun 15;109(23):2911-6. doi: 10.1161/01.CIR.0000129312.43547.08. Epub 2004 Jun 1.
10
Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas.表皮生长因子和层粘连蛋白受体有助于胶质瘤的迁移和侵袭特性。
Invasion Metastasis. 1997;17(5):270-80.

引用本文的文献

1
The protease-activated receptors are expressed in glioblastoma and differentially modulate adherent versus stem-like growth of LN-18 GBM cells.蛋白酶激活受体在胶质母细胞瘤中表达,并对LN - 18胶质母细胞瘤细胞的贴壁生长与干细胞样生长进行差异性调节。
Front Oncol. 2025 Jul 22;15:1582996. doi: 10.3389/fonc.2025.1582996. eCollection 2025.
2
Identification of a coagulation-related gene signature for predicting prognosis in recurrent glioma.用于预测复发性胶质瘤预后的凝血相关基因特征的鉴定
Discov Oncol. 2024 Nov 11;15(1):642. doi: 10.1007/s12672-024-01520-0.
3
Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy.
重新编程免疫抑制性肿瘤微环境:利用血管生成和血栓形成增强免疫治疗。
Front Immunol. 2023 Jul 3;14:1200941. doi: 10.3389/fimmu.2023.1200941. eCollection 2023.
4
Characterization of a novel bispecific antibody targeting tissue factor-positive tumors with T cell engagement.一种新型双特异性抗体的特性研究:该抗体通过T细胞结合靶向组织因子阳性肿瘤
Acta Pharm Sin B. 2022 Apr;12(4):1928-1942. doi: 10.1016/j.apsb.2021.10.028. Epub 2021 Nov 3.
5
Tissue factor potentiates adherence of breast cancer cells to human umbilical vein endothelial cells under static and flow conditions.组织因子增强乳腺癌细胞在静态和流动条件下与人脐静脉内皮细胞的黏附。
Cell Adh Migr. 2021 Dec;15(1):74-83. doi: 10.1080/19336918.2021.1898709.
6
The Ratio of Factor VIIa:Tissue Factor Content within Microvesicles Determines the Differential Influence on Endothelial Cells.微泡内凝血因子VIIa与组织因子含量的比例决定了对内皮细胞的不同影响。
TH Open. 2019 May 15;3(2):e132-e145. doi: 10.1055/s-0039-1688934. eCollection 2019 Apr.
7
Arsenic Trioxide and (-)-Gossypol Synergistically Target Glioma Stem-Like Cells via Inhibition of Hedgehog and Notch Signaling.三氧化二砷与(-)-棉酚通过抑制刺猬因子和Notch信号通路协同作用靶向胶质瘤干细胞样细胞。
Cancers (Basel). 2019 Mar 12;11(3):350. doi: 10.3390/cancers11030350.
8
Phenotypic and Expressional Heterogeneity in the Invasive Glioma Cells.侵袭性胶质瘤细胞中的表型和表达异质性。
Transl Oncol. 2019 Jan;12(1):122-133. doi: 10.1016/j.tranon.2018.09.014. Epub 2018 Oct 3.
9
The Role of Hypoxia in Glioblastoma Invasion.缺氧在胶质母细胞瘤侵袭中的作用。
Cells. 2017 Nov 22;6(4):45. doi: 10.3390/cells6040045.
10
A Systemic Analysis of Transcriptomic and Epigenomic Data To Reveal Regulation Patterns for Complex Disease.基于转录组和表观基因组数据的系统分析揭示复杂疾病的调控模式。
G3 (Bethesda). 2017 Jul 5;7(7):2271-2279. doi: 10.1534/g3.117.042408.